A detailed history of Avalon Trust CO transactions in Abbott Laboratories stock. As of the latest transaction made, Avalon Trust CO holds 5,523 shares of ABT stock, worth $649,780. This represents 0.05% of its overall portfolio holdings.

Number of Shares
5,523
Previous 6,023 8.3%
Holding current value
$649,780
Previous $685 Million 16.17%
% of portfolio
0.05%
Previous 0.06%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$100.73 - $112.44 $50,365 - $56,220
-500 Reduced 8.3%
5,523 $574 Million
Q4 2023

Feb 06, 2024

BUY
$90.19 - $110.4 $36,076 - $44,160
400 Added 7.11%
6,023 $663 Million
Q3 2023

Nov 13, 2023

SELL
$95.53 - $114.62 $8,311 - $9,971
-87 Reduced 1.52%
5,623 $545 Million
Q2 2023

Aug 09, 2023

BUY
$100.78 - $112.29 $19,148 - $21,335
190 Added 3.44%
5,710 $623 Million
Q1 2023

May 11, 2023

BUY
$96.86 - $114.01 $534,667 - $629,335
5,520 New
5,520 $559 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $206B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Avalon Trust CO Portfolio

Follow Avalon Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avalon Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Avalon Trust CO with notifications on news.